Medical
Dalgety medical cannabis press day
Services
-
PR
-
Events
We opened Dalgety’s cutting-edge medical cannabis facility to the press - supporting its ambition to lead the market, drive national recognition, and attract investment in a tightly regulated, emerging sector.
The proof
We built visibility that counts - securing national, high-authority coverage that drove engaged traffic, ignited investor interest, and positioned Dalgety as a credible leader in the UK’s regulated medical cannabis sector.
495%
uplift in website traffic (Jan - Feb 2025, highest on record)
1x
investor roundtable secured with Financial Times
225%
uplift in page-one search rankings (branded + non-branded terms)
Approach
To support Dalgety’s goal of becoming a recognised industry leader, we engaged our health and pharma media network with exclusive press invites - pivoted on its bold mission to build a homegrown supply chain.
We led with a strong editorial hook: Dalgety’s GMP-licensed, single-site delivery model. A timely BBC feature - ranked among December’s most-read stories - boosted credibility, drove media competition, and helped land standout national coverage.
Results
Coverage in Forbes, The Times, and Daily Express amplified Dalgety’s credibility and sparked widespread industry buzz.
A Financial Times feature led to an investor roundtable, supporting long-term growth plans.
Most critically, we positioned Dalgety as a trusted voice ahead of major government discussions - securing its seat at the table in shaping the future of UK medical cannabis.
Let’s grow something great together. Chat to our expert team today about your press day plans - we’ll help you cultivate serious buzz.
Contact us today to discover how our paid social team can lay the foundations of success for you.
